Results 1 to 10 of about 14,174 (227)

Combined Effects of Diazoxide and Moderate-Intensity Exercise on the Restoration of Redox Balance Post-Fatigue in Fast- and Slow-Twitch Skeletal Muscles of Hypertensive Rats [PDF]

open access: goldBiology
Muscle fatigue, defined as a decline in force generation, is closely linked to redox imbalance—a condition exacerbated by oxidative stress in hypertension. This study investigated the effects of diazoxide administration and moderate-intensity exercise on
Estefanía Bravo-Sánchez   +10 more
doaj   +4 more sources

Case Report: Diazoxide-induced diabetic ketoacidosis in a patient with insulinoma [PDF]

open access: goldFrontiers in Endocrinology
Definitive management of insulinoma is challenging as curative surgery is associated with a considerable risk of morbidity and mortality. The successful long-term use of diazoxide for patients diagnosed with insulinoma has been described, but rarely, the
Run Ting Chin   +3 more
doaj   +4 more sources

Real-world experience with the use of diazoxide among people living with congenital hyperinsulinism and their caregivers [PDF]

open access: yesFrontiers in Endocrinology
IntroductionCongenital hyperinsulinism (HI) is a rare disease that causes severe hypoglycemia. Diazoxide is the first-line treatment; however, many individuals using diazoxide continue to experience hypoglycemia. Diazoxide is associated with side effects
Tai L. S. Pasquini   +8 more
doaj   +2 more sources

Ubiquinol-cytochrome c reductase core protein 1 may be involved in delayed cardioprotection from preconditioning induced by diazoxide. [PDF]

open access: goldPLoS ONE, 2017
This study aimed to use long-term diazoxide treatment to establish a loss-of-cardioprotection model and then perform proteomics analysis to explore which proteins of mitochondrial inner membrane (MIM) are potentially involved in delayed cardioprotection.
Zonghong Long   +7 more
doaj   +3 more sources

Oral administration of the KATP channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis [PDF]

open access: goldJournal of Neuroinflammation, 2011
Background Multiple Sclerosis (MS) is an acquired inflammatory demyelinating disorder of the central nervous system (CNS) and is the leading cause of nontraumatic disability among young adults.
Mahy Nicole   +7 more
doaj   +2 more sources

Necrotizing enterocolitis following diazoxide therapy for persistent neonatal hypoglycemia

open access: goldJournal of Pediatric Surgery Case Reports, 2020
Recalcitrant neonatal hypoglycemia poses a treatment challenge for clinicians. When a patient's hypoglycemia does not respond to dextrose infusion, several medication options are available, including diazoxide(1,2).
Christina M. Theodorou, Shinjiro Hirose
doaj   +2 more sources

Identification of an ABCC8 variant in a kindred with transient diazoxide responsive hyperinsulinism [PDF]

open access: yesEndocrinology, Diabetes & Metabolism Case Reports
Congenital hyperinsulinism is a rare disorder characterized by hypoglycemia and inappropriately elevated insulin levels. The genetics of congenital hyperinsulinism is complex, with the most common cause being pathogenic variants in the ATP-sensitive ...
Ryan L Smith, Stephen I Stone
doaj   +2 more sources

Severe transient neonatal hyperinsulinism: First Peruvian case series [PDF]

open access: yesSAGE Open Medical Case Reports
Congenital hyperinsulinism is characterized by dysregulated insulin secretion and is the most common and severe cause of persistent hypoglycemia in pediatrics. Brain damage rates can be as high as 50% due to inadequate treatment.
Manuel André Virú-Loza   +2 more
doaj   +2 more sources

Development and clinical application of a stability-indicating chromatography technique for the quantification of diazoxide

open access: yesHeliyon, 2023
Diazoxide is a potential candidate for the treatment of transitional hypoglycaemia in infants. A clinical trial is currently underway to investigate whether low-dose oral diazoxide is beneficial for severe or recurrent transitional neonatal hypoglycaemia
Trusha J. Purohit   +4 more
doaj   +1 more source

Diazoxide is a powerful cardioprotectant but is not feasible in a realistic infarct scenario

open access: yesFrontiers in Cardiovascular Medicine, 2023
IntroductionDiazoxide is a powerful cardioprotective agent that activates mitochondrial ATP-dependent K-channels and stimulates mitochondrial respiration.
Petra Kleinbongard   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy